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ABSTRACT - Background: The association of hemifacial spasm (HFS), Chiari type I malformation (CIM) and 
neurofibromatosis type 1 (NF1) has not been described yet.  Case report: We report the case of a 31-year-
old woman with NF1 who developed a right-sided HFS. On magnetic resonance imaging (MRI) a CIM was 
seen without syringomyelia. The patient has been successfully treated with botulinum toxin type A injec-
tions for 5 years without major side effects.  Conclusion: Clinical features of HFS, CMI and NF1 are high-
lighted together with their possible relationship. Also, therapeutic strategies are also discussed. 
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espasmo hemifacial em paciente com neurofibromatose e malformação de arnold-chiari: uma 
associação rara
RESUMO - Introdução: A associação entre espasmo hemifacial (EHF), malformação de Chiari tipo I (MCI) e 
neurofibromatose tipo I (NFI) ainda não foi descrita.  Relato do caso: Relatamos o caso de mulher com 31 
anos com NFI que desenvolveu EHF à direita. Na ressonância magnética (RM) foi observada MCI sem serin-
gomielia associada. A paciente foi tratada com sucesso com toxina botulínica tipo A por 5 anos sem efei-
tos colaterais.  Conclusão: Ressaltamos as características clínicas do EHF, MCI e NFI assim como uma possí-
vel relação entre elas. Além disto, discutimos também estratégias terapêuticas. 
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Hemifacial spasm (HFS) is a common movement 
disorder characterized by involuntary tonic or clonic 
contractions of the facial muscles innervated by the 
ipsilateral seventh nerve. In the majority of cases HFS 
is associated with underlying vascular abnormalities 
around the root exit zone of the facial nerve. Sec-
ondary causes of HFS are very unusual1. Chiari type I 
malformation (CIM) originates from a developmental 
pathological condition and is characterized by cau-
dal migration of the cerebellar tonsils. There are few 
case reports on the literature of HFS associated to 
CIM2-4. Neurofibromatosis type 1 (NF1), on the other 
hand, is a genetic autosomal dominant disease (loci 
17q11.2) in which individuals develop both benign 
and malignant tumors at an increased frequency5. 
Single case reports describes the association of CIM 
and NF16. The association of CMI, NF1 and HFS, how-
ever, has not been described yet. 
We report an unique case of HFS probably relat-
ed to CIM in a patient with NF1. We also highlight 
that this association may not be merely fortuitous 
and that even in this scenario long-term use of bot-
ulinum toxin type A (BTX-A) may successfully relief 
symptoms of facial spasm. 
 
caSe 
A Brazilian 31-year-old white woman was referred with 
a 4-year history of paroxystic and irregular facial twitches 
that affected firstly her right upper face and afterwards the 
ipsilateral lower face, without sleep improvement. She had 
no previous history of peripheral facial palsy and was not 
taking any medication. At the age of fifteen she noticed 
few spots on her back skin. There were no other mem-
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bers of her family with movement disorders but her el-
der sister had the same skin lesions. Clinical examination 
showed numerous neurofibromas especially on the face, 
chest and back surfaces. There were also six café-au-lait 
macules. Based on the skin lesions and family history of a 
first-degree relative with the same disease, clinical diagno-
sis of NF1 was made. Neurological examination showed a 
right-sided HFS. There were no other abnormalities in the 
remaining cranial nerves, such as in cerebellar functions 
and other long motor or sensory tracts. On magnetic reso-
nance imaging (MRI) a CIM was seen without syringomyelia 
(Figure). The cerebellar tonsils were herniated caudally un-
til the top level of C2. Treatment was started with BTX-A af-
ter informed consent and permission for data publication. 
Five years later a great improvement is still noticed without 
major side effects. The patient signed informed consent.
diScuSSion
Our case report describes the association between 
HFS, CIM and NF1. To our knowledge this is the first 
case on the literature with this association. Secondary 
HFS is uncommon and among the main causes tumors 
of the cerebello-pontine angle (CPA) such as menin-
giomas, epidermoid cysts or lipomas are well recog-
nized. CIM is also seldom associated with HFS2-4. Cur-
rent evidence support that narrowing of the posterior 
fossa could be one of the mechanisms responsible for 
HFS8. Moreover, patients with Asian origin have shal-
low posterior fossa and it seems that the incidence 
of HFS in this population is higher1. In Brazil, subjects 
of the northeastern region are at greater risk for de-
veloping CIM since they have a singular phenotype 
characterized by shorter neck and shorter stature9. 
Our patient was born in this region of Brazil but on 
clinical examination her neck and body stature were 
on the average size. Therefore, we believe that nar-
rowing of cranio-cervical space due to hindbrain her-
niation might have contributed to the development 
of HFS in our case and that CIM was not associated to 
the classical northeastern Brazilian phenotype. 
CIM has many neurological presentations. The 
main clinical symptoms of CIM are related to the 
compression of neural or dural structures by the in-
feriorly herniated cerebellar tonsils or may be relat-
ed to the associated syringomyelia. Headache is the 
most frequent symptom followed by weakness, sen-
sory abnormalities, lower cranial nerve dysfunction 
and “downbeating” nystagmus10. 
Colpan and Sekerci reported a case of an 18-years-
old boy who presented with a 10-month history of 
HFS due to CIM without syringomyelia. Posterior fos-
sa decompression, C1 laminectomy and duraplasty 
were performed with success and subsequent disap-
pearance of HFS4. Surgical risks of facial nerve de-
compression (impaired hearing and facial weakness), 
however, should not be overlooked. In our case, neu-
rosurgical procedure was not recommended due to 
excellent relief after BTX-A injections. Thus, if we con-
sider that the good resolution of facial spasms were 
obtained and also that posterior fossa decompres-
sion may cause serious side effects such as hearing 
loss and facial palsy, each case may have to be sepa-
rately analyzed to better decide treatment options. 
Apart from HFS and CIM our patient was diag-
nosed with NF1 which, similarly to CIM, has challeng-
ing clinical presentations. The recognized neurologi-
cal complications of NF1 are nerve sheath tumors, 
optic gliomas, cognitive deficits, “unidentified bright 
objects” (hyperintense T2 brain MRI lesions), seizures 
and macrocephaly5. 
Bony lesions are very frequent among patients 
with NF1 and are also considered as part of the clini-
cal diagnostic criteria for NF15. According to recent 
data CIM might not be a casual association to NF1. 
This is supported by a prevalence study on CIM and 
NF17. It was shown that in 130 young patients with 
surgically addressed CIM 5.4% of them had NF1. On 
the other hand, 198 patients diagnosed with NF1 had 
in 8.6% of the cases a CIM radiologically confirmed, 
suggesting that CIM and NF1 are not spurious find-
ings but rather true associations. 
Thus, one may consider that CIM is part of the of 
NF1 spectra and ultimately may be responsible for 
Figure. Sagittal T1-weigthed brain MRI scan, showing Chiari 
type 1 malformation. Ectopia of the cerebellar amygdalae de-
scending to top level of C2 is seen.
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HFS. It is our opinion that patients with NF1 and HFS 
should be routinely scanned, preferably with MRI, 
with the purpose to find cranio-cervical malforma-
tions or tumors arising from the CPA. 
In conclusion, although the majority of cases of 
HFS are related to vascular abnormalities around the 
root exit zone of the ipsilateral facial nerve, second-
ary cases due to CIM should always be remembered, 
especially in patients with NF1. Moreover, even in 
this scenario, management with BTX-A may provide 
convincing relief. 
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